GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (OTCPK:OXBOF) » Definitions » EPS without NRI

Oxford BioDynamics (Oxford BioDynamics) EPS without NRI : $-0.08 (TTM As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Oxford BioDynamics EPS without NRI?

Oxford BioDynamics's earnings per share without non-recurring items for the six months ended in Sep. 2023 was $-0.04. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.08.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -12.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -28.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Oxford BioDynamics's EPS without NRI or its related term are showing as below:

OXBOF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -48.5   Med: -19.95   Max: 42.2
Current: -12

During the past 11 years, Oxford BioDynamics's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 42.20% per year. The lowest was -48.50% per year. And the median was -19.95% per year.

OXBOF's 3-Year EPS without NRI Growth Rate is ranked worse than
69.49% of 1298 companies
in the Biotechnology industry
Industry Median: 5.3 vs OXBOF: -12.00

Oxford BioDynamics's EPS (Diluted) for the six months ended in Sep. 2023 was $-0.05. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.09.

Oxford BioDynamics's EPS (Basic) for the six months ended in Sep. 2023 was $-0.05. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.09.


Oxford BioDynamics EPS without NRI Historical Data

The historical data trend for Oxford BioDynamics's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics EPS without NRI Chart

Oxford BioDynamics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.06 -0.10 -0.09 -0.08

Oxford BioDynamics Semi-Annual Data
Sep13 Sep14 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.05 -0.05 -0.04 -0.04

Competitive Comparison of Oxford BioDynamics's EPS without NRI

For the Biotechnology subindustry, Oxford BioDynamics's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioDynamics's PE Ratio without NRI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's PE Ratio without NRI falls into.



Oxford BioDynamics EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford BioDynamics  (OTCPK:OXBOF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Oxford BioDynamics EPS without NRI Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics (Oxford BioDynamics) Business Description

Traded in Other Exchanges
Address
Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.

Oxford BioDynamics (Oxford BioDynamics) Headlines

From GuruFocus